HCA Healthcare, Inc. (NYSE:HCA) Stock Has Consensus Target Price of $467.61

Shares of HCA Healthcare, Inc. (NYSE:HCA) have earned a consensus rating of “Moderate Buy” from the twenty-four analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $467.61.

A number of equities research analysts have commented on the company. UBS Group reduced their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. TD Cowen lifted their price objective on HCA Healthcare from $431.00 to $460.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. Mizuho decreased their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Finally, Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 7th.

Institutional Investors Weigh In On HCA Healthcare

Institutional investors have recently bought and sold shares of the stock. Anchyra Partners LLC grew its position in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the period. SBI Securities Co. Ltd. increased its holdings in HCA Healthcare by 24.7% in the 3rd quarter. SBI Securities Co. Ltd. now owns 111 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares in the last quarter. Beacon Capital Management LLC boosted its holdings in HCA Healthcare by 0.7% in the 3rd quarter. Beacon Capital Management LLC now owns 3,631 shares of the company’s stock worth $1,550,000 after buying an additional 25 shares during the period. Diversify Advisory Services LLC raised its holdings in HCA Healthcare by 3.3% during the third quarter. Diversify Advisory Services LLC now owns 806 shares of the company’s stock valued at $378,000 after acquiring an additional 26 shares during the period. Finally, AdvisorNet Financial Inc raised its stake in HCA Healthcare by 3.5% during the 3rd quarter. AdvisorNet Financial Inc now owns 994 shares of the company’s stock valued at $468,000 after purchasing an additional 34 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $469.45 on Friday. The stock has a fifty day moving average of $431.58 and a 200-day moving average of $418.97. The stock has a market capitalization of $101.64 billion, a P/E ratio of 15.72, a price-to-earnings-growth ratio of 1.58 and a beta of 1.10. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the business earned $6.84 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, research analysts forecast that HCA Healthcare will post 29.45 earnings per share for the current year.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Attractive valuation: Zacks identifies HCA as a strong value stock, which may appeal to investors seeking a relatively inexpensive healthcare company with potential for market-beating returns. Here’s Why HCA Healthcare Is a Strong Value Stock
• Positive Sentiment: Defensive investor interest: A broader rotation toward high-quality, defensive companies in healthcare and other essential sectors could provide a supportive backdrop for HCA stock. Defensive Rotation Toward Quality Companies
• Positive Sentiment: Expansion in Florida: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term market expansion and future capacity. Cape Coral Approves Incentives for HCA Hospital
• Neutral Sentiment: Upcoming earnings catalyst: HCA is scheduled to report third-quarter results around October 27. Investors are focused on admissions, occupancy, inpatient revenue and other operating metrics, with the report likely to determine the stock’s next significant move. HCA Third-Quarter Earnings Preview
• Neutral Sentiment: Workforce investment: HCA opened a clinical training center in Gainesville, which may strengthen its healthcare staffing pipeline but is unlikely to materially affect near-term earnings. HCA Opens Clinical Training Center
• Negative Sentiment: Mixed earnings outlook: Higher admissions, occupancy and inpatient revenue could help third-quarter results, but rising costs and fewer outpatient surgeries may pressure margins and temper investor expectations. Will HCA Earnings Benefit From Higher Admissions?

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.